To target the EGFR, Sym004 undergoes a combination of inhibitory mechanisms that allows it to target a broad patient population.
Sym004 undergoes a combination of inhibitory mechanisms. This is to target the EGFR. This combination of inhibitory mechanisms allows it to target a broad patient population.